Matthew E. Wand
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Health top 0.5%
- Vaccine Coverage and Hesitancy
Papers in
-
- Antibiotic Resistance in Bacteria 24
-
- SARS-CoV-2 and COVID-19 Research 6
- Antimicrobial Resistance in Staphylococcus 5
- Co-authors
- J. Mark Sutton (38 shared papers)Lucy J. Bock (16 shared papers)Laura C. Bonney (3 shared papers)Richard W. Titball (4 shared papers)Claudia Müller (2 shared papers)Charlotte K. Hind (12 shared papers)Stephen L. Michell (2 shared papers)Philip G. Nugent (2 shared papers)
- Journals
- Journal of Medical Microbiology (5 papers)Microbiology (4 papers)Scientific Reports (4 papers)Journal of Hospital Infection (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Matthew E. Wand
58 papers receiving 6.5k citations
Matthew E. Wand's Hit Papers
Peers
Comparison fields: 5 of 146
- Infectious Diseases 3.8k
- Health 1.1k
- Molecular Medicine 668
- Modeling and Simulation 527
- Endocrinology 251
Countries citing papers authored by Matthew E. Wand
This map shows the geographic impact of Matthew E. Wand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Wand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Wand more than expected).
Fields of papers citing papers by Matthew E. Wand
This network shows the impact of papers produced by Matthew E. Wand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Wand. The network helps show where Matthew E. Wand may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Wand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 2 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 3 | 2016 | 251 | |
| 4 | 2020 | 251 | |
| 5 | 2016 | 144 | |
| 6 | 2011 | 118 | |
| 7 | 2007 | 90 | |
| 8 | 2022 | 79 | |
| 9 | 2018 | 66 | |
| 10 | 2013 | 65 | |
| 11 | 2016 | 63 | |
| 12 | 2015 | 56 | |
| 13 | 2011 | 54 | |
| 14 | 2015 | 54 | |
| 15 | 2015 | 52 | |
| 16 | 2002 | 49 | |
| 17 | 2011 | 49 | |
| 18 | 2017 | 48 | |
| 19 | 2018 | 46 | |
| 20 | 2018 | 44 |
About Matthew E. Wand
Matthew E. Wand is a scholar working on Molecular Medicine, Infectious Diseases, Endocrinology, Organic Chemistry and Pollution, having authored 61 papers that have together received 6.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (24 papers), Bacterial biofilms and quorum sensing (9 papers), Antimicrobial agents and applications (8 papers), Bacteriophages and microbial interactions (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (6 papers), Bacterial Genetics and Biotechnology (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). The work is most often cited by research in Infectious Diseases (3.8k citations), Health (1.1k citations), Molecular Medicine (668 citations), Modeling and Simulation (527 citations) and Endocrinology (251 citations). Matthew E. Wand has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include J. Mark Sutton, Lucy J. Bock, Laura C. Bonney, Richard W. Titball, Claudia Müller, Charlotte K. Hind, Stephen L. Michell, Philip G. Nugent, Mark Alexander Webber and Laura J. V. Piddock. Their work appears in journals such as Journal of Medical Microbiology, Microbiology, Scientific Reports, Journal of Hospital Infection and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.